OR WAIT null SECS
November 30, 2021
Five-year deal covers manufacturing of molecules, ranging from monoclonal antibodies to antibody-drug conjugates
November 29, 2021
Subject to regulatory approval, CDMO will produce mRNA vaccine on a commercial scale
November 16, 2021
Opens a ‘Cold Chain Packaging Center of Excellence’ in Kentucky, while expanding services globally
November 12, 2021
It’s not just innovator pharma companies concerned with the proposed compromise to Medicare price negotiations and inflation-based rebates
November 10, 2021
CDMO’s expansion of Hopkinton, MA facility will include seven new ISO 7 cGMP suites
November 09, 2021
Deal expected to boost firm’s offerings via FDS's delivery system services
November 01, 2021
Anticipated capacity of GMP facility is 60 million vials per year
October 28, 2021
Additional equipment to be added to the plant next year
October 27, 2021
Development project features additional manufacturing suites, expansion of storage capabilities
October 26, 2021
mRNA jab maker plans to initially produce 50 million Covid vaccine doses per year
